Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S1W-22467 · Session 1

Further to the answer to question S1W-21523 by Malcolm Chisholm on 21 January 2002 and given that local management in NHS Greater Glasgow s…

Answered Asked by Dorothy-Grace Elder SNP Lodged 29 Jan 2002

The question

To ask the Scottish Executive, further to the answer to question S1W-21523 by Malcolm Chisholm on 21 January 2002 and given that local management in NHS Greater Glasgow supports the use of Herceptin for the treatment of secondary breast cancer, whether this drug is currently being prescribed on the NHS to any of the patients clinically suitable for receiving the treatment and what the reasons are for the position on this matter.

The answer

Answered by Malcolm Chisholm on 12 Feb 2002 · 14 days after it was lodged, on time

As stated in my answer to question S1W-21523 on 21 January 2002, NHS Greater Glasgow supports the use of Herceptin, which is a licensed medicine currently being prescribed by NHS doctors in accordance with agreed local protocols. Individual treatment decisions are agreed between clinicians and their patient and are bound by the rules of patient confidentiality.

In the Official Report

No contribution in the Official Report cites S1W-22467 by reference.